Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan added to standard therapy for scleroderma renal crisis
2010-021452-26Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bosentan in scleroderma renal crisis (SRC), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Renal function evolution, Glomerular blood flow and 2 more. Started Jul 2010; status: completed.
02
Drugs
bosentan
03
Conditions
scleroderma renal crisis (SRC)
Beyond the preview
Go deeper on 2010-021452-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021452-26.